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While a clear heritable risk has been observed for congenital heart disease, there is
considerable variation in penetrance and presentation likely due to multiple genetic and
environmental risk factors. To identify causative factors and interactions responsible for variability
in heart development, greater than 4,200 hearts from Nkx2-5 heterozygous knockout mice have
been collected and examined. Nkx2-5+/- mice in the inbred strain background C57Bl/6 frequently
have atrial and ventricular septal defects. The incidences are substantially reduced in the Nkx2-5+/progeny of first-generation (F1) outcrosses to the strains FVB/N or A/J. Defects recur in the
second generation (F2) of the F1xF1 intercross or backcrosses to the parental strains. All 3 strains
carry susceptibility alleles at different loci for atrial and ventricular septal defects. Relative to the
other 2 strains, A/J carries polymorphisms that confer greater susceptibility to atrial septal defect
(ASD) and atrioventricular septal defects and C57Bl/6 to muscular ventricular septal defects
(VSD). Genome wide linkage analysis was conducted on 306 mice from the FVB/n F2 intercross
and 80 mice from the A/J F2 intercross diagnosed with VSD to map main effect and interacting
loci that correlate with risk. Additionally the possibility of environmental interactions was
explored in this analysis by including maternal and paternal age and litter size as terms in the
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models tested. Significantly linked genomic regions were identified from the FVB/n population on
chromosomes 6, 8 and 10 implicating genes in these positions as important candidates for VSD
risk. Linkage analysis on the A/J cross identified both shared and unique modifiers from the
FVB/N cross scan. Maternal age was found to significantly correlate with VSD risk in FVB/N
crosses but not A/J providing evidence for strain specific susceptibility to a non-heritable risk
factor. The findings in this study implicate modifier genes as major factors in cardiac
developmental pathways by buffering against genetic and environmental insults in the majority
while directing the manifestation of disease in a few. Characterization of the genetic architecture of
congenital heart disease in a mouse model will provide a deeper understanding of its multifactorial
nature and possibly lead to novel strategies for prognosis and prevention.
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Chapter 1: Introduction and Background Review
Literature Review
Congenital Heart disease (CHD) is a complex disease occurring with an incidence
of 1 in 100 live births and it is the leading cause of defect-related death among newborns
in the United States 1,2. Surveys from diverse locales and periods showed a remarkably
consistent ~0.5% incidence of significant congenital heart disease in newborns. The
distribution of defects assumes a regular pattern with ventricular septal defects (VSDs)
being the most common, followed by atrial septal defects (ASDs) and atrioventricular
canal defects (AVCs) 3. It is suspected that this complex of diseases is caused by
disruptions at various points along the cardiac developmental pathway resulting in a
malformed heart. With a strong recurrence in 1st degree relatives, there is a clear genetic
component to congenital heart disease risk, but its study is complicated by genetic
heterogeneity as well as variable penetrance and expressivity 4,5. Even when individuals
are carrying a common genetic risk factor there is considerable variability in phenotypic
outcome6. As early as 1968 Nora et al described congenital heart disease as having a
multifactorial model of inheritance; or the result of multiple genetic and environmental
factors and interactions7.
The most important advances in this field have come from the discovery of
human disease causing mutations in cardiac transcription factor genes such as Tbx5,
GATA4 and Nkx2-58-10. But, studies exemplifying syndromes with highly penetrant heart
defects have resulted in an emphasis on monogenic causes that highlight the outdated
genetic determinism paradigm where one gene is linked to one phenotype. The vast
1

majority of congenital heart disease occurs sporadically and is not due to obvious
mutations in major genes 1,3. Studies addressing sporadic incidences have identified
numerous candidate loci that show correlation with cardiac malformations but
mechanistic explanations remain incomplete 1,11. There lacks a framework that relates the
known major genes and candidate loci to each other in the context of functional
developmental pathways. A coherent model would require a better understanding of the
underlying variability including genes with smaller effects on the cardiac regulatory
pathway and potential environmental risk factors that may interact with them.
One potential approach to a better understanding of congenital heart disease is
dissecting the evolutionary basis for the heart’s inherent complexity. Heart development
occurs early in gestation with the first heart beats occurring 21-23 days into human
embryonic development and the completion of the four chambers and outflow tract at 7
weeks 12. The developmental sequence is replicated in birds and mammals and is
governed by a highly conserved gene regulatory pathway. The first heart began as a
simple tube with contractile functions in our distant aquatic ancestors, however millions
of years of gene duplication and co-option of additional genetic networks have resulted in
multiple chambers, valves, inflow and outflow tracks and a conduction system as seen in
mammals. A series of transcription factors have been identified as playing a major role in
morphogenesis but there still lacks a comprehensive model of upstream regulators and
downstream activators to complete our understanding 13. Multiple genetic factors
affecting CHD makes sense as this is a vital and complex system that has been evolving
for many millions of years. The polygenic risk of CHD may provide a clue to how the
heart survives and remains a relatively robust organ system. Perhaps there is considerable
2

variation in small effect genes so that if a major genetic or environmental disruption to
the system occurs, there will be a whole host of options for the system to evolve from14.
It seems that this system would develop out of millions of years of stabilizing selection to
maintain an organ that is robust to change. This presents an important problem in
understanding points of failure in development underlying the epidemiology of
congenital heart defects because different modifiers may direct disease in different
populations.
NKX2-5 Cardiac Transcription Factor
Nkx2-5 is an ancient and well characterized gene that encodes for an NK2-type
homeodomain cardiac transcription factor important in heart development. The NK2
homeobox is an ancient regulator of cardiac muscle cell lineages and has been reported to
be co-expressed with MEF2, a central muscle gene regulator existing in Cniderians which
lack a heart but contain the myoepithelial cells thought to be similar to the evolutionary
precursors of myocytes 15. The Nkx2-5 gene is well conserved because its integral role in
heart development is ubiquitous across animal species. Homozygous Nkx2-5 knockout
mice form an underdeveloped heart that is non-functional and therefore 100% embryonic
lethal. Developing embryos show a heart tube that is only partially looped and has a
bulbous atrium and ventricle, a wide, regurgitant atrioventricular canal, and a stenotic
outflow tract. The embryo dies at E9.5 16,17. However in heterozygous knockout mice,
animals normally survive to birth but their risk increases for a wide array of heart defects
and thus, implicates other genetic and environmental elements as being important in heart
development.
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In human babies, mutations within have been linked to AV block, atrial and
ventricular septal defects, tetralogy of Fallot, Ebstein’s anomaly and other tricuspid valve
abnormalities 18. While it is understood that Nkx2-5 is one of a series of highly conserved
transcription factors that make up a core set of regulators in heart development13, the
variation in congenital heart disease cannot be attributed to the heterogeneity of the many
mutations described in these core genes alone. Nkx2-5 disruption has resulted in an
increased risk for a variety of different cardiac malformations among individuals within
the same pedigree indicating that a specific Nkx2-5 mutation does not condemn a person
to a specific defect 10.

Mouse Model for Human Disease
The mouse serves as an excellent model for congenital heart disease because the
human NKX2-5 haploinsufficient pleiotropy described above can be mimicked in inbred
strains using heterozygous knockouts. These mice show an elevated risk for a variety of
heart malformations and despite being in a more controlled environment than their human
counterparts, mice show proportionately similar incidences of the different types of heart
defects with VSDs being the most common followed by ASDs and then atrioventricular
canal defects. Mating, living environment and diet can be controlled, and by choosing
markers polymorphic between strains, there is no ambiguity of allelic ancestry so that
outcrosses are 100% informative at each marker in linkage analysis. Different inbred
strains can provide simple homogeneous models for the effects of variable genetic
backgrounds seen in different individual human subjects. Human allelic background and
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diversity can thus be modeled in mice in the context of genetic risk for human disease
19,20

. Strain-dependent variability of cardiac defects has been described in major heart

genes such as Hey2, Tbx1 and Tbx5 21-23. This observation implies that while these genes
have been identified as causative factors of human disease, genetic background plays an
important role in directing the CHD phenotype. It is suspected that innate polymorphisms
within modifier loci for the core genes mentioned are fixed in inbred lines resulting in
strain specific variability. These loci can potentially affect alternative sub-networks of
morphogenesis resulting in a propensity towards defects unique to the line.
In this study we have crossed Nkx2-5+/- C57Bl/6 mice with wild type FVB/n and
A/J to form an F1 hybrid generation which was then intercrossed to create two F2
generations in which each mouse has a unique combination of alleles from the parental
lines. By outcrossing isogenic mice, the overall proportion of genomic heterozygosity can
be experimentally varied. In general, genetic hybrids show an increased fitness when
compared to their 99% homogeneous isogenic parents, a phenomenon called heterosis or
hybrid vigor 24. Heterosis has primarily been studied in the context of agriculture;
particularly to investigate the origins of quantitative traits that affect biomass and fertility
in plants and livestock 25. However it has implications in human disease as well since the
source of vigor or lowered risk could be the result of evolutionarily beneficial diversity at
loci that have yet to be discovered. By elucidating the genetic differences among
individuals that direct them towards or away from a specific defect, a more complete
model of heart developmental pathways can be established.

5

BACKGROUND DATA
Homozygous Nkx2-5 knockout mice form an underdeveloped heart that is nonfunctional and therefore 100% embryonic lethal. Nkx2-5+/- C57Bl/6 isogenic mice are
born with ASDs and/or VSDs ~55% of the time, but when these mice are outcrossed to
FVB/n mice their offspring show a dramatic drop in incidence (~4%). The reduction in
heart defects in the hybrid generation implicates genetic heterozygosity elsewhere in the
genome as a major effecter on heart development.

Nkx2-5+/- F1 hybrid show decreased disease incidence
To generate the F2 animals, Nkx2-5+/- C57Bl/6 males are crossed to FVB/N
females to generate the F1 hybrid mice. The F1 generation is genotyped through PCR for
Nkx2-5+/- knockout and then F1 animals are intercrossed to generate F2 progeny. F2
neonates are collected within hours of birth to prevent cannibalization and in order to
keep track of population genotype frequencies. The neonates are euthanized, dissected
and genotyped for Nkx2-5. The mouse torso sections are fixed in 10% neutral buffered
formalin for 2 nights and then transferred to 70% EtOH. The fixed hearts are dissected
out, paraffin-embedded and serially sectioned completely in the frontal plane at 6 μm
thickness. The cardiac tissue is stained with hemotoxylin and eosin for examination
under a 5x microscope objective. Diagnoses of heart defects are independently validated
for each heart.

6

Crosses between the C57Bl/6 and
FVB/N strains are shown. Pies depict
the fraction of the genome from either
strain with gray representing a random
distribution in the population.

Figure 1. Breeding strategy.
Serial sectioned hearts from wild-type and Nkx2-5+/- neonatal pups in the isogenic
C57Bl/6 background revealed a 17% incidence of ventricular septal defect and a 17%
incidence of atrial septal defect (Fig. 2) which is significantly different (P > 0.01) from
the 49 wild-type hearts diagnosed; all of which showed normal heart morphology.
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Figure 2. The most common defects observed in hearts with Congenital Heart Disease.
Sectioning and diagnosis of 52 WT and 57 Nkx2-5+/- F1 C57Bl/6-FVB/n newborn
hearts showed a significant reduction is defects will all WT being structurally normal and
one ASD and a small VSD detected in Nkx2-5+/- neonate hearts (Table 1). The reduction
of ASD and VSD incidences in Nkx2-5+/- F1 progeny compared to isogenic Nkx2-5+/C57Bl/6 mice was found to be significant (P > 0.01) for this outcross.
Because different inbred strains are likely fixed for their own distinct
combinations of polymorphisms which can result in strain specific effects on defect
incidence and presentation 26 another outcross was performed using the WT A/J mice. In
the C57Bl/6-A/J outcross, no VSDs were observed in hybrid WT or Nkx2-5+/- hearts
resulting in a significant reduction of VSD incidence compared to parental Nkx2-5+/8

mice. Interestingly, ASD incidence was found not to be significantly affected by
hybridization since 4 ASDs were diagnosed out of the 49 F1 C57Bl/6-A/J Nkx2-5+/- mice
examined. While more complex mechanisms may underlie this finding, it is likely that
one or more ASD susceptibility loci are not polymorphic between C57Bl/6 and A/J and
thus risk reduction through increased heterozygosity is not observed as in the C57Bl/6FVB/n hybrids. Another explanation may be the presence of dominant A/J
polymorphism(s) conferring susceptibility in the heterozygous state as well. The F1
generational loss of VSDs in the presence of Nkx2-5+/- denotes a recovery from
inbreeding depression and/or the introduction of hybrid vigor. This change in defect
incidence through a reduction of homozygosity is indicative of a reliance of the cardiac
phenotype on genetic variation outside of the Nkx2-5 locus.

F2 intercross show a recovery of defects
Given the observation that F1 hybrids showed a risk reduction for CHD in the
presence of Nkx2-5+/-, it was predicted that subsequent backcrosses to parental strains
and intercrosses would increase the incidence of CHD since the F2 crosses would result
in a proportion of loci reverting back to homozygosity. If recessive CHD susceptibility
loci reestablish a homozygous state, disease risk should be recovered.
Mice from the Nkx2-5+/- C57Bl/6-FVB/n and C57Bl/6-A/J F1 hybrid generations
were backcrossed to C57Bl/6 and separately intercrossed (C57Bl/6-FVB/n F1 x
C57Bl/6-FVB/n F1, C57Bl/6-A/J F1 x C57Bl/6-A/J F1) to form F2 populations from
which hearts were collected, sectioned and diagnosed.
9

Ventricular septal defects in the F2 C57Bl/6-FVB/n population remained
significantly higher (P = 0.0053) in Nkx2-5+/- mice than in the WT mice (Fig. 3). Nkx25+/- atrial septal defect incidence did not reach significance compared to WT F2 progeny
(P = 0.1199) however, this is likely due to ASDs being more rare and thus lowering the
number of affected animals so that stochastic events have more influence. Intercross
progeny showed a recovery of defects with a VSD incidence of 15.1% and an ASD
incidence of 6.0% out of the 974 Nkx2-5+/- pups collected and diagnosed. VSD incidence
was significantly increased (P = 0.0004) from the previous F1 hybrid generation. Since
the status of the Nkx2-5 heterozygous genotype remained constant, an increase in defects
from the F1 to F2 generations supports the existence of one or more genomic loci that
modify the Nkx2-5+/- risk for heart defects.
F2 A/J intercross VSD incidence was significantly elevated from the previous F1
generation resulting in 10.8% having VSDs out of 465 diagnosed hearts (P = 0.0089).
The 6.7% ASD incidence observed was not appreciably different than the F1 incidence
lending support to the hypothesis that ASD susceptibility loci may not be polymorphic
between C57Bl/6 and A/J or that there are dominant A/J risk allele(s) that confer similar
risk in Aa and AA form. C57Bl/6 backcross mice showed a modest increase in VSD
incidence of 10.9% while the ASD incidence of 7.9% was consistent with the
corresponding intercross data as it was not dissimilar from the F1 generation. F2 A/J
Nkx2-5 heterozygous mice showed significantly higher incidences for VSDs and ASDs
than their WT counterparts (P = 0.0001 and P = 0.0012 respectively).

10

Conclusion
It is the goal of this study to characterize the genetic variation that is typical of
congenital heart disease. An inbred C57Bl/6 mouse that has a heterozygous knockout for
the cardiac transcription factor Nkx2-5 will serve as a model for risk. Controlled breeding
to other inbred strains will allow for genetic variability to be re-introduced so that we
may study its effects on the phenotype. Through observation, segregation, linkage and
correlation analyses, this model will be systematically tested to determine the effects of
yet unknown sources of genetic variation. The new information gathered from this study
can then be applied to our current understanding of the heart developmental pathway so
that a more accurate model of congenital heart disease may then be applied to improve
standard of care for the afflicted population.
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Chapter 2: Heterogeneity of Genetic Modifiers Ensures Normal Cardiac Development
Published in Circulation, March 2010
Abstract
Mutations of the transcription factor Nkx2-5 cause pleiotropic heart defects with
incomplete penetrance. This variability suggests that additional factors can affect or
prevent the mutant phenotype. We assess here the role of genetic modifiers and their
interactions. Heterozygous Nkx2-5 knockout mice in the inbred strain background
C57Bl/6 frequently have atrial and ventricular septal defects. The incidences are
substantially reduced in the Nkx2-5+/- progeny of first-generation (F1) outcrosses to the
strains FVB/N or A/J. Defects recur in the second generation (F2) of the F1xF1 intercross
or backcrosses to the parental strains. Analysis of greater than 3000 Nkx2-5+/- hearts from
5 F2 crosses demonstrates the profound influence of genetic modifiers on disease
presentation. On the basis of their incidences and coincidences, anatomically distinct
malformations have shared and unique modifiers. All 3 strains carry susceptibility alleles
at different loci for atrial and ventricular septal defects. Relative to the other 2 strains, A/J
carries polymorphisms that confer greater susceptibility to atrial septal defect and
atrioventricular septal defects and C57Bl/6 to muscular ventricular septal defects.
Segregation analyses reveal that at least 2 loci influence membranous ventricular septal
defect susceptibility, whereas at least 2 loci and at least 1 epistatic interaction affect
muscular ventricular and atrial septal defects. Alleles of modifier genes can either buffer
perturbations on cardiac development or direct the manifestation of a defect. In a
genetically heterogeneous population, the predominant effect of modifier genes is health.
15

Introduction
Significant progress has been made toward defining genetic etiologies in
congenital heart disease.1,2 Current knowledge of the few dozen genes implicated in
cardiac development does not explain, however, the basis of common epidemiologic and
clinical observations. The incidence of heart defects in newborns is 0.5-1%, making it a
leading cause of death in children. Still, the vast majority is born with a normal heart.
Selection against fetuses that have cardiac defects does not cause the prevalence of the
norm.3,4 Insults on the embryonic heart may be rare or weak, or mechanisms may have
evolved to ensure the robustness of development. Direct evidence for either hypothesis is
minimal, but the latter can better explain the breadth of observations related to
incomplete penetrance and phenotypic variability.5,6
Although family studies led to the discovery of mutations of prototypical cardiac
developmental genes such as TBX5, NKX2-5, and GATA4 7-10, most cases of congenital
heart disease have no identified cause or association. Such sporadic cases may be due to
an unknown teratogen, spontaneous mutation or inconsistent expression of an inherited
etiology. The last possibility is supported by the increased incidence of congenital heart
disease in subsequent first-degree relatives, 2-11%, compared to the general
population.11-13 Some normal relatives of sporadic patients must somehow escape the
manifestation of a genetic mutation. Furthermore, among the affected relatives the
cardiac phenotypes are usually dissimilar and of wide-ranging severity.11,13 Modifying
factors likely influence the incomplete penetrance and phenotypic variability associated
with the expression of a causative mutation. In a family, the activity of modifiers in
16

pathways involved in the development of an affected cardiac structure could determine
whether a particular relative develops a heart defect, its type and severity. The unknown
factors could be genetic, environmental or entirely stochastic. Of these, genetic modifiers
are most amenable to investigation in a laboratory where environmental factors can be
controlled between experimental groups.
Small studies have demonstrated the effect of the background strain on cardiac
phenotypes related to embryonic viability and myocardial, valvar, or ventricular septal
morphology in Tbx5, Gata4 and Hey2 mutations.14-16 The extent to which genetic
modifiers contribute to incomplete penetrance and phenotypic variability as observed in
humans might only be appreciated, however, in a much larger study. In this regard, the
diverse anatomic phenotypes described in association with NKX2-5 mutation offer a
foothold into the genetic modifiers that influence the susceptibility of developmental
pathways. NKX2-5 mutations were first reported in families with highly penetrant ASDs
and atrioventricular block, but not every member of these and subsequent families who
carried a mutation had an ASD or even a cardiac malformation. Among affected persons
the various defects seem neither related to each other by any known developmental
pathway nor correlated with NKX2-5 genotype.9,17,18 Thus, while mutations of NKX2-5
or other cardiac transcription factors like TBX5 and GATA4 undoubtedly cause heart
defects, modifying factors could have effects on phenotype as great as the causative
mutation.
As the first step toward the elucidation of these factors, we examined the effect of
genetic background variation on the incidence of specific heart defects in heterozygous
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Nkx2-5 knockout animals in the inbred mouse strain C57Bl/6 and in crosses to the strains
FVB/N and A/J. The survey of thousands of Nkx2-5+/- animals reveals the important role
that genetic modifiers play in buffering cardiac developmental pathways against a major
perturbation in a population while directing the manifestation of disease in a few. The
results intertwine the genetic basis of health and congenital heart disease, providing a
conceptual framework to understand common clinical observations.
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Methods
Mouse Strains and Crosses
Nkx2-5+/- animals were backcrossed to C57Bl/6 for 10-13 generations. The
knockout allele was generated and genotyped as described.19 Nkx2-5+/- C57Bl/6 males
were crossed to FVB/N or A/J females to generate F1 progeny. C57Bl/6 and FVB/N
animals were obtained from Charles River Laboratories, and A/J from the Jackson
Laboratory. Nkx2-5+/- F1 animals were intercrossed or backcrossed to the parental strains
C57Bl/6 or FVB/N to generate F2 progeny. The backcross to A/J was not performed.
Animals were housed under standard conditions in the same room and fed the same
chow. The experiments were approved by the animal studies committee at Washington
University School of Medicine.
Diagnosis of congenital heart defects
Neonatal pups were collected each morning within hours of birth to prevent
cannibalization of animals that have serious congenital heart defects. The pups were
euthanized. The thorax was fixed in 10% neutral buffered formalin overnight and then
transferred to 70% ethanol. Fixed hearts were dissected, embedded in paraffin, and
entirely sectioned in the frontal plane at 6 µm thickness. Each heart was inspected under
a 5x microscope objective by at least two individuals. Defects were diagnosed by the
appearance of the septae, valves, or blood in consecutive sections. Genomic DNA was
isolated from every animal by phenol-chloroform extraction.
Statistical analyses
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To compare the genotypic distribution in a particular strain or cross to the
expected Mendelian ratio, all the pups from consecutive litters were counted up to at least
100 animals. Statistically significant deviation was defined in a χ2-test by P < 0.05.
The incidence of specific types of heart defects in crosses were compared by a
two-tailed Fisher’s exact test. The co-incidence of heart defects in the same mouse was
evaluated by comparison to the expected incidence, as determined by the product of their
separate incidences, using a χ2-test.
Correlation of muscular and membranous VSD incidence with the average
number of C57Bl/6 alleles per locus as expected from the Mendelian distribution in the
F2 crosses was evaluated by Pearson’s product-moment correlation followed by a twotailed t-test with significance defined by P < 0.05.
Segregation models were analysed by comparison of their predictions and
observed incidences by a χ2-test. The models and derivation of equations are detailed in
the Supplemental Materials.
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Results
Newborn Nkx2-5+/- animals in the C57Bl/6 background have a high incidence of ASD
and VSD
Human NKX2-5 mutations cause congenital heart defects, some of which are
lethal if untreated in the newborn period. While such serious defects in Nkx2-5+/- mice
have not been described, we observed that ~17% of Nkx2-5+/- pups in the C57Bl/6
background were missing at 2-3 weeks of age when they were weaned from their
mothers. The attrition of Nkx2-5+/- animals occurs after birth because newborn pups were
obtained at the expected Mendelian ratio (Table 2.1). We therefore examined newborn
hearts that were collected within hours of birth. A high incidence of ASD of the
secundum type was found in Nkx2-5+/- but not wild-type hearts (Figures 2.1, 2.2). A
secundum ASD was diagnosed by an insufficiency in covering the fossa ovale due to a
deficiency in its rim or of the septum primum. Hearts in which a potentially small ASD
could not be distinguished from a patent foramen ovale were considered normal. The
ASD incidence is greater than the ~20% previously reported by two different groups for
adult Nkx2-5+/- animals in the C57Bl/6 background possibly because of spontaneous
closure or postnatal death.20-22 VSDs of the membranous and muscular types were also
found in Nkx2-5+/- but not wild-type hearts (Figures 2.1, 2.2). VSDs were not previously
reported in adult animals possibly because of spontaneous closure or death from
pulmonary overcirculation in the newborn period, as seen in mouse mutants that have a
persistent patent ductus arteriosus.23
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Previous investigators have detected aortic stenosis by Doppler echocardiography
in live animals and bicuspid aortic valves by gross examination of adult Nkx2-5+/animals.21 Given that we examined histologic sections, minor valvular abnormalities that
might cause regurgitation or stenosis are difficult to assess. Abnormal blood flow
patterns have also been described by fetal echocardiography in association with severe
lesions like truncus arteriosus.24 Severe defects and ones not easily detected by
echocardiography like small VSDs because of physiologically elevated right-sided
pressures in the fetus and newborn are easily recognized because of the greater spatial
resolution of microscopy.
Nkx2-5+/- animals in hybrid strain backgrounds generally have normal cardiac anatomy
Nkx2-5+/- animals in the C57Bl/6 background were outcrossed to the FVB/N
strain. The F1 progeny, which are C57Bl/6 X FVB/N hybrids, showed the expected
Mendelian ratio of Nkx2-5+/- pups at weaning (Table 2.1). The absence of neonatal lethal
defects was confirmed by direct inspection. Only one small VSD and 6 ASDs were
found among 80 Nkx2-5+/- F1 newborn mouse hearts. All 52 wild-type hearts were
normal. The incidence of either septal defect in the Nkx2-5+/- C57Bl/6 X FVB/N F1
hybrids is significantly lower compared to the C57Bl/6 background (Figure 2.2).
Nkx2-5+/- animals from the C57Bl/6 X A/J F1 hybrid cross similarly showed the
expected Mendelian distribution of genotypes at weaning (Table 2.1). Direct inspection
confirmed a reduced incidence of heart defects compared to the C57Bl/6 background,
none of which was expected to be lethal. No VSDs and only 4 ASDs were found among
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54 C57Bl/6 X A/J F1 Nkx2-5+/- newborn hearts. All 48 wild-type hearts were normal
(Figure 2.2).

The C57Bl/6 X FVB/N F2 crosses reveal ASD and VSD susceptibility alleles in both
strains
The C57Bl/6 X FVB/N F1 hybrid data suggest that C57Bl/6 carries one or more
recessive alleles of modifier genes that increase susceptibility to heart defects in the
presence of Nkx2-5 mutation. The data do not exclude the possibility of recessive
susceptibility alleles from FVB/N at other loci. To investigate these possibilities, Nkx25+/- F1 animals were backcrossed to C57Bl/6 and FVB/N or intercrossed to generate F2
progeny. Newborn F2 pups showed the expected Mendelian distribution of genotypes,
which indicates the absence of selection against defects that could cause prenatal demise
(Table 2.1).
VSD and ASD were more common in the Nkx2-5+/- animals from each of the
C57Bl/6 X FVB/N F2 crosses than from the F1 but less common than in C57Bl/6 (P <
0.001 for comparisons to both the F1 and C57Bl/6). A VSD was present in 12-16% of
the Nkx2-5+/- F2 hearts, and an ASD in 4-7% (Figure 2.3). These results indicate that at
least two loci affect VSD and ASD susceptibility in the presence of Nkx2-5 mutation.
C57Bl/6 and FVB/N carry recessive, susceptibility alleles at different loci, given the
increased incidence in the parental backcrosses compared to the F1. The Nkx2-5+/- F2
may have a lower incidence of particular defects compared to C57Bl/6 either because
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FVB/N susceptibility genotypes have smaller effects or because interactions between
C57Bl/6 and FVB/N alleles reduce risk.
The C57Bl/6 X A/J F2 crosses reveal A/J susceptibility alleles for ASD and
atrioventricular septal defects
Similar to the C57Bl/6 X FVB/N F2 results, the Nkx2-5+/- F2 progeny from the
C57Bl/6 X A/J intercross and C57Bl/6 backcross showed an incidence of VSD and ASD
greater than the F1 and less than C57Bl/6 (P < 0.001 for each of the comparisons; Figure
2.3). The backcross to A/J was not performed. Comparing the C57Bl/6 X A/J to the
C57Bl/6 X FVB/N F2 crosses revealed two significant differences.
First, ASDs occurred at a higher frequency in the C57Bl/6 X A/J F2 intercross
than in the C57Bl/6 X FVB/N (P < 0.001). There was a similar trend between the F2
backcrosses to C57Bl/6, which was not significant possibly because of the smaller
sample sizes (P < 0.1). A/J may carry polymorphisms that confer greater susceptibility
specifically to ASDs in the presence of Nkx2-5 mutation. The A/J polymorphisms do not
increase susceptibility to septal defects in general because the VSD incidence was not
different between the two intercrosses.
Second, atrioventricular septal defects (AVSD) occur at a low but significant
incidence in the Nkx2-5+/- C57Bl/6 X A/J F2 intercross (Figures 2.3 and 2.4). Nkx2-5
mutation causes the defect because none of 238 wild-type littermates from the same cross
had an AVSD (P < 0.05). An A/J polymorphism enhances susceptibility because the
defect is much rarer in the C57Bl/6 X FVB/N F2 intercross (P < 0.001). The A/J
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polymorphism appears dominant with low penetrance because one AVSD was found
among 121 Nkx2-5+/- hearts from the backcross to C57BL/6.
Double-outlet right ventricle occurs rarely in Nkx2-5+/- F2 animals
Double-outlet right ventricle (DORV), in which both great arteries arise from the
right ventricle and the aortic and mitral valves are separated by a muscular conus, has
been reported in association with human NKX2-5 mutation. Two Nkx2-5+/- F2 animals
were found to have DORV, one each from among 1552 C57Bl/6 X FVB/N and 1104
C57Bl/6 X A/J intercross hearts examined (Figure 2.4). The rarity of DORV precludes
conclusions about the role of modifier genes in its pathogenesis. We note, though, that
defects associated with human NKX2-5 mutation that are more common than DORV in
the general population like hypoplastic left heart syndrome have not been found in any
Nkx2-5+/- mouse.17,18,25 Such defects may have not been found either because the sample
size remains too small or because the inbred strains examined do not carry the relevant
susceptibility alleles.
Genotypes at multiple modifier loci determine the VSD phenotype
Membranous and muscular VSDs are found in Nkx2-5+/- hearts, but muscular
VSDs are more common in the C57Bl/6 background (P < 0.0005; Figure 2.5). Which
type of VSD develops appears to be determined by the cumulative effect of susceptibility
genotypes at multiple modifier loci for either defect. We compared the incidence of each
VSD type to the fraction of the C57Bl/6 genome in the genetically heterogeneous F2
crosses, as expected from a Mendelian distribution (Figure 2.5). There was a strong,
positive correlation for muscular VSD (r = 0.91, P < 0.04) and a negative correlation for
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membranous VSD (r = -0.97, P < 0.006). Thus, C57Bl/6, FVB/N and A/J all carry
recessive, susceptibility alleles at multiple loci for either VSD phenotype, but in the
mixed strain backgrounds the additive effect of the C57Bl/6 susceptibility genotypes is
less or greater than the other two strains for membranous and muscular VSD,
respectively. Additional epistatic effects between loci may also influence the incidence
of specific congenital heart defects, as shown by segregation analyses below.
ASD and VSD co-occur more frequently than expected by chance in Nkx2-5+/- hearts of
mixed genetic background
Polymorphic modifier genes clearly influence the development of specific types
of defects in Nkx2-5 mutation. To test the hypothesis that the same polymorphism could
increase susceptibility to two different defects, the incidence of hearts having both
defects was compared to the product of the individual defect incidences in the population,
i.e., the chance or null hypothesis. VSD and ASD co-occur more often than expected by
chance in the C57Bl/6 X FVB/N intercross and the C57Bl/6 X A/J intercross and
backcross to C57Bl/6 (Figure 2.6A). In the two F2 intercrosses where the sample sizes
are large, ASD co-occurred with either muscular or membranous VSD more often than
expected (Figure 2.6B). On the other hand, muscular and membranous VSD did not cooccur more often than expected. The co-occurrence of AVSD with other heart defects
was not evaluated because of its low incidence. Therefore, some modifiers may increase
the susceptibility to several types of heart defects in the presence of Nkx2-5 mutation
whereas others may affect the development of just one.
Segregation analysis of the genetic architecture of common septal defects
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To characterize the genetic architecture of modifiers that influence ASD and VSD
susceptibility in Nkx2-5+/- animals, we examine two segregation models. The models
focus on the C57Bl/6 X FVB/N crosses because data from F2 backcrosses to both
parental strains are available. How well the predictions of a model fit the observed data
set lower bounds on the number of modifiers and interactions that are involved in the
pathogenesis of particular defects.
The first model, M1, postulates two loci A and B that do not interact. C57Bl/6
and FVB/N carry the recessive, susceptibility alleles of A and B, respectively. The
effects of susceptibility genotypes at A and B are estimated from the incidences in the
C57Bl/6 strain and the F2 backcross to FVB/N. The expected incidences in the F2
intercross and C57Bl/6 backcross are then calculated from the model. Inclusion in the
model of additional loci does not alter its predictions because the total effect of
susceptibility alleles from one strain reduces to a single term. The predictions deviate
significantly from the observed incidences of ASD and muscular VSD (P < 0.0001) but
approximate the membranous VSD incidences (P = 0.14. Figure 2.7A-C). Therefore, at
least two loci affect all three defect types.
Model M2 permits interaction between two modifier loci. In the simplest case,
C57Bl/6 carries the recessive susceptibility alleles at two modifier loci A and B, which
interact synergistically. FVB/N carries the recessive susceptibility allele at a third locus
C. If the effect of A or B alone is negligible compared to their interaction, then the
incidence of the defect in C57Bl/6 provides an estimate of the epistatic effect. Based on
this model, the incidences attributed to the epistatic effect and locus C, as estimated from
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the F2 FVB/N backcross, match the observed incidences of muscular VSD in the F2
intercross and C57Bl/6 backcross (Figure 2.7A).
M2 underestimates the incidences of membranous VSD in the F2 intercross and
C57Bl/6 backcross (P < 0.0001, Figure 2.7B). M2 may not model the genetic
architecture of membranous VSD because either epistatic interactions have no role (i.e.,
M1 is correct) or there are unaccounted interactions between C57Bl/6 and FVB/N alleles
at other loci.
M2 poorly fits the ASD incidences in the F2 intercross and C57Bl/6 backcross (P
< 0.0001; Figure 2.7C). ASDs appear more genetically complex than VSD. First,
additional loci and interactions must be postulated to account for the >4-fold difference in
the incidence of ASD between the C57Bl/6 backcross and C57Bl/6. Inspection of the
incidences in the crosses indicates that more than two modifier loci in each of the lines
are likely be involved. Second, M1 and M2 predict the absence of defects in the F1
because homozygosity of a susceptibility allele at a modifier locus is assumed necessary
for a defect. The assumption appears reasonable for muscular and membranous VSDs
but not for ASD. The presence of ASDs in the F1 suggests that heterozygosity at some
loci confer susceptibility.
Taken together, the two segregation models indicate that three or more modifier
loci and at least one epistatic interaction influence the susceptibility to muscular VSD and
ASD in Nkx2-5+/- animals. At least two loci influence membranous VSD susceptibility.
The loci and interactions inferred from the C57Bl/6 X FVB/N crosses probably represent
only a subset of all that exist among inbred mouse strains or the human population. A
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more precise estimate of the number of modifier loci in the mouse model, whether
independent or epistatic, involved in any of the defects requires additional information,
such as genetic linkage analyses that are underway.
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Discussion
Normal cardiac development is critical for the survival of an individual. Any
mechanism that could ensure normal development would increase the fitness of a species.
In the short term, natural selection would eliminate major deleterious mutations. In
contrast, stabilizing selection could promote the evolution of a versatile system that
buffers the effects of genetic and environmental perturbations to the developing heart.
The invariance of the normal heart form would then be enhanced.6 Waddington
described the general mechanism metaphorically as “canalization” in which development
flows down channels to produce a highly invariant wild-type form. He considered the
depth of the channels analogous to the degree of buffering, which he deduced to have a
genetic basis.26 Crucial phenotypes are maintained about a stable optimum. Sufficiently
great insults, however, decanalize an individual and reveal the influence of cryptic
variants of modifier genes that do not affect the phenotype of genetically wild-type
individuals.5 Investigation of modifier genes thus provides an alternative approach to the
genetic pathways that shape a normal heart. Cryptic polymorphisms within them may
give rise to much of the complexity of congenital heart disease.
The results of inbred strain crosses indicate that modifier genes contribute to the
canalization and decanalization of cardiac development in the presence of Nkx2-5
mutation. A large fraction of Nkx2-5+/- animals in the C57Bl/6 background has atrial and
ventricular septal defects, whereas few among F1 hybrid crosses to FVB/N or A/J do.
Defects recur in F2 crosses at a lower incidence than in C57Bl/6. We interpret this to
mean that strain-specific polymorphisms of modifier genes alter the susceptibility of
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certain cardiac developmental pathways to Nkx2-5 mutation but do not affect the wildtype form. Complementation of susceptibility alleles in the F1 and homozygosity at
some but not all modifier loci in the F2 contribute to the relative differences in defect
incidence in the successive crosses. Furthermore, analysis of the incidences of ASD and
VSD in the F2 crosses and C57Bl/6 suggest that modifier loci act independently of or
epistatically with other loci. Thus, a protective allele at a modifier locus might directly
reduce the risk of a defect or abrogate a synergistic interaction between loci that increases
risk.
The surprisingly normal hearts of Nkx2-5+/- animals from the F1 hybrid crosses
illustrate the important role of polymorphic modifier genes in ensuring the robustness of
cardiac development. Protective polymorphisms likely exist against a variety of insults,
as reductions in heart defect incidence have also been observed in Tbx5 or Gata4 mutants
in mixed compared to isogenic strain backgrounds.14,15 The greater heterogeneity in
humans could provide even more genetic material to buffer against numerous, potentially
common insults like nutrient deprivation or congenital infection. For well-canalized
traits, cryptic variation can accumulate in a population in the absence of a major
perturbation because the phenotype is buffered against change.5 Natural selection due to
diverse pressures in the wild could also maintain heterogeneity because normally cryptic
polymorphisms may be protective or detrimental depending upon the context. The
resulting genetic architecture could ensure that a fraction of the population survives
almost any particular perturbation.
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Recessive susceptibility alleles of modifier genes exist in each of the three inbred
strains examined, given the presence of defects in the Nkx2-5+/- F2 progeny from all the
parental backcrosses and intercrosses. Our statistical analysis of thousands of hearts
reveals that modifier genes fixed for different variants in the inbred strains influence the
development of specific types of defects in the presence of Nkx2-5 mutation. Relative to
the other strain backgrounds, C57Bl/6 carries polymorphisms that increase the
susceptibility to muscular VSD, and A/J carries polymorphisms that increase the
susceptibility to ASD and AVSD. Modifier genes reside in pathways that affect the
development of individual or multiple anatomic structures like the atrial and ventricular
septum, based upon the higher than expected co-incidence of some defects. The
observations inform how modifier loci and interactions could be mapped to define the
genetic pathways leading from Nkx2-5 mutation to various types of defects.
Even genetic diseases thought to exhibit simple Mendelian inheritance manifest
with incomplete penetrance and varying phenotypes. The properties of genetic modifiers
of the Nkx2-5 mutant phenotype help to explain the basis of the variable presentations of
congenital heart disease. Ostensibly sporadic cases of congenital heart disease could
result from germline or somatic mutations, teratogens, or purely stochastic events. Our
results offer an alternative, but not mutually exclusive possibility that polymorphisms of
genetic modifiers can either suppress or promote the effect of a major mutation.
Maximum genetic heterogeneity in the F1 is associated with near complete suppression
of deleterious phenotypes, leading to normal carriers. On the other hand, homozygosity
at some loci in the F2 contributes to the manifestation of a specific defect among multiple
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potential phenotypes, which in a heterogeneous human population could appear like
sporadic disease or pleiotropic defects.
This large study, which systematically varies the genetic background of a mouse model,
offers insights into how genetic modifiers ensure normal cardiac development and
influence the manifestation of congenital heart disease. Knowledge resulting from the
characterization and identification of the modifiers in the mouse will almost certainly be
relevant to human disease because pathways in cardiovascular development and
physiology are strongly conserved. For example, dozens of quantitative trait loci that
affect blood pressure are common between rodent models and human populations.27,28
Cardiac development is robust. Appreciating how, one could conceivably mimic nature
to reduce the heavy burden of congenital heart disease on children and their families.
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Figures:
Figure 2.1. Atrial and ventricular septal defects in newborn Nkx2-5+/- animals. An intact
ventricular septum (A) and a normal atrial septum with a patent foramen ovale (B) in
wild-type hearts. (C) Membranous VSD and (D) muscular VSD in Nkx2-5+/- hearts. (E)
Secundum ASD in an Nkx2-5+/- heart. Arrowheads point to the relevant defect in each
section. Ao, Aorta. RA, LA, right, left atrium. RV, LV, right, left ventricle.

Figure 2.2. The incidence of septal defects in wild-type and Nkx2-5+/- animals in the
C57Bl/6 background and in F1 crosses to FVB/N and A/J. The incidence of ASD and
VSD in Nkx2-5+/- hearts is substantially reduced in the F1 hybrids compared to the
C57Bl/6 parental strain (P < 0.001).

Figure 2.3. The incidence of specific heart defects in Nkx2-5+/- animals from F2
intercrosses and parental backcrosses of C57Bl/6 and FVB/N or A/J. Cross-specific
differences in the incidence of ASD and AVSD are significant between the C57Bl/6 X
FVB/N and C57Bl/6 X A/J F2 intercrosses. The incidence of VSD is comparable
between the C57Bl/6 X FVB/N and X A/J F2 crosses.

Figure 2.4. Rarer heart defects are found in Nkx2-5+/- F2 progeny. Sections through an
Nkx2-5+/- heart from the C57Bl/6 X A/J F2 intercross demonstrate an atrioventricular
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septal defect with its VSD (A), common valve (B) and primum ASD (C) marked by
arrowheads in each section. Sections through an Nkx2-5+/- heart from the C57Bl/6 X
FVB/N F2 intercross demonstrate double outlet right ventricle with the pulmonary artery
(D, PA) and aorta (F, Ao) both arising from the right ventricle. An intermediate section
(E) demonstrates the side-by-side arrangement of the great arteries.

Figure 2.5. The incidence of muscular and membranous VSD among the F2 crosses and
C57Bl/6 background is determined by the cumulative effect of multiple, strain-specific
susceptibility genotypes. Muscular VSD is more common in Nkx2-5+/- animals in the
C57Bl/6 background than membranous (P< 0.0005). In the F2 crosses, muscular VSD
incidence is positively correlated with the average fraction of the C57Bl/6 genome in the
progeny (R = 0.91, P < 0.02). Membranous VSD is negatively correlated (R = -0.97, P <
0.003). The average number of C57Bl/6 or non-C57Bl/6 alleles per locus based on a
Mendelian distribution in each F2 cross is noted. MBR, membranous VSD. MUSC,
muscular VSD.
Figure 2.6. Some modifier loci may contribute to the development of both ASD and
VSD. (A) ASD and VSD co-occur in the F2 intercrosses and C57Bl/6 backcross of the
C57Bl/6 X A/J F1 more often than expected by the null hypothesis of complete
independence between the defects. (B) The co-incidence rates are subdivided by VSD
types in the two intercross populations, which have sufficiently large sample sizes for
statistical comparison.

38

Figure 2.7. Segregation analyses define the minimum number of modifier loci and
interactions involved in the susceptibility to ASD and VSD. The observed and expected
incidences of (A) muscular VSD, (B) membranous VSD, and (C) ASD are predicted in
the Nkx2-5+/- C57Bl/6 X FVB/N F1 and F2 progeny under two segregation models.
Model M1 postulates two loci that do not interact. M2 postulates three loci, two of which
interact.

M1 approximates the observed incidences of membranous VSD but fits

muscular VSD and ASD poorly. M2 fits muscular VSD well but not ASD or
membranous VSD. Both models predict no defects in the F1, which contrasts with the
ASDs observed.
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Chapter 3: Characterization of Modifiers of Congenital Heart
Disease in an Nkx2-5+/- risk Model
Abstract
While a clear heritable risk has been observed for congenital heart disease, there
is considerable variation in penetrance and presentation likely due to multiple genetic
and environmental risk factors. To identify causative genetic and environmental factors
and interactions responsible for variability in heart development, greater than 4,200
hearts from Nkx2-5 heterozygous knockout mice have been collected and examined.
Genome wide linkage analysis was conducted on 306 mice from the FVB/n F2
intercross and 80 mice from the A/J F2 intercross diagnosed with VSDs to map main
effect and interacting loci throughout the mouse genome that correlate with risk.
Additionally the possibility of environmental interactions was explored in this analysis
by including maternal and paternal age and litter size as additive and interactive terms
in the models tested. Significantly linked genomic regions were identified from the
FVB/n population on chromosomes 6, 8 and 10 implicating genes in these positions as
important candidates for VSD risk. Linkage analysis on the A/J cross identified both
shared and unique modifiers from the FVB/N cross scan. Maternal age was found to
significantly correlate with VSD risk in FVB/N crosses but not A/J providing evidence
for strain specific susceptibility to a non-heritable risk factor. The findings in this study
implicate modifier genes as major players in cardiac developmental pathways by
buffering against genetic and environmental insults in the majority of a population
while directing the manifestation of disease in a few. Characterization of the genetic
architecture of congenital heart disease in a mouse model will provide a deeper
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understanding of its multifactorial nature and possibly lead to novel strategies for
prognosis and prevention.

Introduction
Congenital heart disease is the top source of birth defect related death and a
major burden on our health care system as 10% of these children require 1 or more
surgeries in their lifetime 1. With a 16% incidence in offspring of affected patients, it
is clear that a strong genetic component exists and thus epidemiological patterns have
been studied extensively over the last 50 years 2. Up until the past decade, syndromes
with highly penetrant heart defects have resulted in an emphasis on monogenic causes
that highlight the outdated genetic determinism paradigm where one gene is linked to
one phenotype. Pleiotropy further complicates the disease model as most disease
causing mutations described increase risk for a number of different types of defects.
Congenital heart disease has thus been reported as having a multifactorial model of
inheritance indicating that multiple genes and environmental factors are to blame for
the variability in disease manifestation 3.
Despite heart defects being a major health concern for 1 in every 120 babies
born in the United States, the phenotype for the other 119 babies is a normal heart.
The complexity of the system may reflect redundancy, and compensatory regulatory
interactions that buffer the system to genetic and environmental perturbations 4. The
range of phenotypes segregating within human families and among different inbred
mouse backgrounds with a common disease gene reflects the influence of an
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underlying genetic distribution 5. The effects of mutations in major heart development
genes are likely modified by other factors which may be genetic or environmental.
Investigating modifiers is challenging because their phenotypic effects might
only become observable in the context of a dramatic perturbation of the regulatory
network that controls heart development. Gibson et al has coined the term cryptic
variation to describe this phenomenon which is likely the rule rather than the
exception in complex disease etiology. Important information lies in this genetic
variance because while specific alleles of genetic modifiers may cause congenital
malformations, it is likely that other variants are responsible for buffering the effects
of mutations in major heart genes and thus responsible for how robust heart
development is the majority of the time.
In this study we investigate potential sources of variability in risk using a
simple inbred mouse model system in which much of the variation that occurs in
natural populations can be controlled for. Both heritable and non heritable modifiers
may affect penetrance, dominance deviation, expressivity and pleiotropy, but only in
the presence of a major heart gene mutation 6. The Nkx2-5 heterozygous knockout
mouse in the C57Bl/6 inbred strain served as a near homogeneous, disease vulnerable
population in which we could add in genetic sources of variability to observe the
affect on heart disease risk. Outcrossing this mouse to two other inbred strains
provided for variability in genetic background that could then be mapped to identify
genetic modifiers. Non heritable risk factors such as parental age and litter size were
also noted as potential sources of variability in disease risk.
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In this study, we seek to parse out the underlying variation that affects heart
defect incidence and presentation through genetic linkage mapping. In addition, we
explore how environmental variance due to non heritable factors such as parental age
of the F2 pups and litter size might modify disease risk. Once we are able to isolate
the different sources of variance responsible for the complex nature of congenital
heart disease, the medical community will be considerably better equipped to prevent
and protect against this debilitating health problem.

Methods

Mouse Strains and Breeding
Nkx2-5+/- mice were backcrossed to C57Bl/6 for 10-13 generations. The
knockout allele was generated and genotyped as previously described 7. The C57Bl/6
and FVB/N inbred strains were obtained from Charles River Laboratories and the A/J
strains from the Jackson Laboratories. Nkx2-5+/- C57Bl/6 males were crossed to
FVB/N females to generate the F1 hybrid mice. Nkx2-5+/- F1 animals were
intercrossed to generate F2 progeny as described 8. Animals were housed under
standard conditions in the same room and fed the same chow. The experiments were
approved by the animal studies committee at Washington University School of
Medicine.
Approximately 4,200 F2 neonates were collected within hours of birth to
prevent cannibalization and to keep track of population genotype frequencies. The
neonates were euthanized, dissected and genotyped for the Nkx2-5 knockout through
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standard PCR protocol. The mouse torso sections were fixed in 10% neutral buffered
formalin for 2 nights and then transferred to 70% ethanol. The fixed hearts were
dissected out, paraffin-embedded and serially sectioned completely in the frontal
plane at 6 μm thickness. The cardiac tissue was stained with hematoxylin and eosin
for examination under a 5x microscope objective. Diagnoses of heart defects were
independently validated by at least two people for each heart and recorded (Table
3.1). Genomic DNA was isolated from every animal by standard phenol-chloroform
extraction.

SNP Genotyping
Approximately 120 SNPs polymorphic between C57Bl/6 and FVB/n or A/J
mouse strains were chosen for genome wide coverage of the 19 autosomes at an
average density of 15-20cM. SNPs with common alleles between FVB/n and A/J
were chosen whenever possible. High throughput genotyping was accomplished using
the Sequenom MassARRAY system at the Human Genetics Division Genotyping
Core at Washington University.

Statistical Analysis
Linear dependence between non heritable factors; litter size, maternal and
paternal age was evaluated using the Pearson Product Moment correlation. Logistic
regression using the R statistical software package was then carried out to determine
correlation of the binary heart phenotype with each of the continuous non heritable
variables. Maternal and Paternal age were log transformed prior to analysis to adjust
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for skewness and kurtosis. Statistical significance was defined by P < 0.05. Because
correlation was evident between the predictors, multiple logistic regression was
performed anytime multiple predictors for a heart phenotype were found to be
significant. Odds ratios and adjusted odds ratios where determined from the
regression coefficients along with 95% confidence intervals.
To detect risk loci, genome-wide linkage analysis was conducted with Interval
mapping using the R/QTL software package. A total of 251 C57Bl/6 x FVB/n F2
mice with membranous VSDs and 80 mice muscular VSDs as well as 285 control
mice were included in the genome scan. For the C57Bl/6 x A/J cross, 87 F2 mice with
membranous VSDs and 116 controls were included in the analysis. The heart defects
were found to occur evenly in both sexes indicating a lack of sex specific effects. The
Expectation-Maximization algorithm with a binary model was specified to generate
LOD scores representing the likelihood of linkage at a particular genomic region.
Main effect scans evaluated the probability of VSD risk linkage at each marker
genotyped as well as imputed marker genotypes at 5.0 cM intervals between true
markers. The scan is designed to detect the presence of single QTL effects throughout
the mouse genetic map.
Both litter size and maternal age were added to single effect scans as additive
and then interactive covariates separately. The additive covariates account for
potential residual variance and the interactive covariates detect gene by covariate
specific interactions. A LOD score exceeding a 0.05 threshold alpha value was
considered significant.
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The Genome wide threshold of significance was determined through the use
of permutation analysis as described by Sen and Churchill 9. Greater than 5000
permutations were conducted for each main effect scan run. This method has the
strength of taking the data structure into account as it randomizes the genotypes with
respect to phenotypes for each permutation. The weakness of this method is that it
can give inflated significance to smaller sample sized runs ( n < 100 affected) 10.

A two-dimensional (two-way) scan was conducted to account for the potential
effects of multiple genetic loci, some of which may interact. The interaction may be
additive, synergistic or more complex as when the expression of one locus depends
on the genotype of another (an epistatic interaction). Each marker (including imputed
markers) is tested in combination with every other marker for correlation with
phenotype. The following models are considered in this analysis for each of the locus
pair combinations as described in Broman et al11,12.

Full:

(y) = β0+ β1(qtl1) + β2(qtl2) + β3(qtl1,qtl2) + ε

Additive:

(y) = β0+ β1(qtl1) + β2(qtl2) + ε

Single QTL: (y) = β0+ β1(qtl1) + ε
Null:

(y) = β0+ ε

The models are then compared to generate five LOD scores:

LODf = Full – Null
LODa = Additive – Null
LODfv1 = Full – Single
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LODav1 = Additive – Single
LODi = Full - Additive

Genome wide thresholds for significance for all five LOD scores tested were
generated with 1000 permutations for the two-way scans.

FullT

Fv1T

IntT

AddT

Av1T

OneT

8.51

6.69

6.1

5.85

2.79

3.44

Loci of interest were identified by two dimensional scan results based on
recommendations by Broman at all in which multiple LOD score thresholds are
interpreted in combination:

(1) LODf > FullT and either LODfv1 > Fv1T or LODi > IntT
(2) LODa > AddT and LODav1 > Av1T

Satisfaction of condition (1) indicates evidence for two loci in which there is
potential for epistatic interactions. In contrast, condition (2) solely supports evidence
that there are two loci interacting additively.
Two-way genome wide scans have high and sometimes stifling thresholds of
significance to account for the large number of tests being conducted. Larger sample
sizes are required since there are 9 possible biallelic genotypes that need to be
represented for each marker locus. Single effect genome scans were also conducted
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with significant candidate peaks as covariates. Scans were conducted with a candidate
locus set as an additive covariate and then compared to scans with the candidate locus
as an interactive covariate. Any regions which show a significant jump in LOD score
would be considered to be evidence of an interaction, however only subject to single
genome wide scan thresholds because of prior knowledge of the candidate.
Models including significant main effect loci and non heritable variables were
tested using the fitqtl function provided in R/qtl in order to estimate the percentage of
phenotypic variance explained 11. A drop analysis was also conducted with this
function to test models in which each term was successively dropped and then
compared to the full model.

Results

Heritable Risk Factors
Linkage analysis on the binary phenotype of (VSD presence/No defects) was
performed to detect significant main effect loci across the genome indicating
locations of potential risk modifying candidates (Figure 3.1). The F2 intercross
generation of the C57Bl/6 x FVB/n cross yielded 3 loci located on chromosomes 6, 8
and 10 with logarithm of odds (LOD) scores exceeding the 3.44 threshold of
significance (α = 0.05) defined by permutation analysis.
Based on the physiological differences between membranous and muscular
VSDs, linkage scans were also conducted on these phenotypes separately. Removal
of the muscular VSDs from the membranous data results in a reduction in false
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positives for any main effect loci that are not associated with muscular VSD risk. The
membranous VSD specific scan showed increases in LOD scores for loci on
chromosomes 8 and 10 despite the reduction of sample size of affected mice (Figure
3.2). The increase is evidence of distinct genetic etiologies of these two defects
specifically suggesting that loci on chromosomes 8 and 10 are only important for
membranous VSD risk and not muscular. In contrast, the chromosome 6 candidate
peak showed a modest decrease in significance suggesting that this peak may be a
shared risk factor for the two types of VSDs. The muscular VSD phenotype showed
considerably reduced signals without any genomic regions exceeding the α threshold
of 0.05 as well as greater background noise (Figure 3.3). A reduced sample size
(n=80 affecteds) probably is a major contributor to the lack of significance in this
scan. However, the data may also be indicative of a more genetically heterogeneous
risk profile in which the presence of a large number of small effect genes directs
penetrance of the phenotype. The peak on chromosome 6 appears to be common
between the two types of VSDs indicating some commonality in the disease pathways
of the two defects.
Inheritance patterns of each significant peak show risk alleles originating from
both C57Bl/6 and FVB/n strains as hypothesized in Winston et al through segregation
analysis on this data (Figure 3.4)8. Both chromosome 8 and 10 follow a semi
recessive inheritance which is consistent with the lack of VSDs in F1 hybrid mice.
Chromosome 6 shows the risk allele being inherited semi-recessively from the
C57Bl/6 parent were as chromosome 8 has the risk allele inherited semi-recessively
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from the FVB/n parent. In the case of chromosome 10, the risk allele is inherited from
the C57Bl/6 parent with no dominance effects detected.
Genome wide scans for the F2 C57Bl/6 x A/J mice with membranous VSDs
yielded loci on chromosomes 3 and 4 that exceeded the genome wide α = 0.05
threshold of significance (Figure 3.5). The effect plots show that both of these
candidate regions have their risk allele being inherited from the A/J inbred line
(Figure 3.6). In the case of the chromosome 3 peak there appears to be no dominance
effects whereas for peak on chromosome 4, risk is inherited recessively. Both of these
peaks are not present in the FVB/n F2 genome scans indicating that A/J mice have
risk factors specific to their strain. Of particular interest are peaks present on
chromosomes 8 and 10 in very close proximity to the significant loci on
chromosomes 8 and 10 mapped in the FVB/n membranous VSD scan although in the
A/J scan, they do not achieve genome wide significance. The A/J chromosome 8 and
10 loci also share similar inheritance patterns which is further evidence that these are
truly common risk factors between FVB/n and A/J F2 intercross mice. Given the
differences in VSD incidence between F2 FVB/n and A/J mice (Table 3.1) it is
expected that at least some of the risk loci are strain specific as is the case here.
Of particular interest is the lack of major heart development genes within the
three candidate gene intervals on chromosomes 6, 8 and 10. Only chromosome 8 has
genes implicated in heart defect risk, Hand2 and Tll1, located very close to the region
of peak LOD score. Hand2 has been implicated as being in a common pathway with
Nkx2-5 and involved in ventricular septal development13,14. It has been reported that
Tll1 is activated by Nkx2-5 and also important in cardiac septation15,16. Likely, the
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genetic modifiers at the other two loci will prove to be genes that have novel
relationships to the cardiac developmental pathway.

Non-heritable Risk Factors
Paternal and maternal ages and litter size were evaluated as potential risk
factors for increased membranous VSD incidence in C57Bl/6 x FVB/n and A/J F2
intercross mice. Analysis of 2,400 F2 intercross heterozygous Nkx2-5+/- knockout
mice collected showed a significant positive correlation for maternal age with
membranous VSD defect incidence (P = 0.006, OR = 4.07) in the FVB/n intercross
(Table 3.2). Litter size was found to negatively correlate with VSD risk in FVB/n (P=
0.002, OR=0.92) although the effect size is considerably smaller (Figure 3.7). These
two non-heritable risk factors are significantly correlated (P < 0.001, R = -0.35)
independently of VSD incidence since older mice have smaller litters, however this is
adjusted for in the multiple logistic regression model. Paternal age did not show a
significant correlation with membranous VSD risk. In the case of muscular VSD risk,
there were considerably fewer affected mice but a significant maternal age affect was
detected (P=0.03, OR=2.99).
A total of 1,370 A/J F2 intercross mice were analyzed for correlation with the
three non-heritable risk factors. C57Bl/6 x A/J F2 intercross mice show a significant
maternal age affect on membranous VSD risk (P=0.02, OR=3.96) but not muscular
VSDs. Additionally, litter size was found to significantly affect muscular VSD
incidence in these mice although with a marginal effect size (P=0.02, OR=1.14).
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Interaction Scan
A two-way genome scan for interacting loci was performed to assess potential
interactions between loci as might be expected for complex disease susceptibility.
The interaction scan was only run on membranous VSD data since larger sample
sizes are required to exceed the very stringent genome wide thresholds of
significance. An initial genome wide scan was run in which every marker locus was
tested in combination with every other marker locus (Figure 3.8). The threshold for
significance was generated by 1000 permutations:

FullT

Fv1T

IntT

AddT

Av1T

OneT

8.51

6.69

6.1

5.85

2.79

3.44

The two-way genome wide scan yielded three pairs of loci that satisfied
condition 1 (Table 3.3). Each pair consists of genomic regions that exceeded genome
wide thresholds in the previous main effect scan, loci on chromosomes 6, 8 and 10,
indicating that the effect of these regions may be enhanced by the genotypes of one
another. The interactive LOD score for each pair did not exceed genome wide
thresholds indicating that this may be a purely additive or synergistic effect and likely
not a true case of epistasis. These locus pairs also satisfied the condition 2 threshold
confirming at least an additive interaction between them.
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To further check whether yet undetected loci are interacting with the main
effect regions mapped on chromosomes 6, 8 and 10, each locus was tested as an
additive and then interactive covariate in order to compare the results of the two
scans. There were no major jumps in LOD scores between these scans which supports
the conclusion that in this model, no epistatic interactions have been detected (data
not included).

Covariate addition
Since maternal age is a risk factor for VSD in FVB/n F2 intercross mice,
genome-wide linkage scans were run including maternal age as an additive and then
as an interactive covariate. The additive covariate accounts for residual variance in
the population of mice due to maternal age. A negligible increase in power resulted
from this adjustment. Maternal age was also included as an interactive covariate to
scan for regions in the genome that are specifically affected by variance in maternal
age. No significant jumps in LOD score were detected. Inclusion of litter size as an
additive covariate showed marginal improvement in LODs scores of peak regions.
There was no evidence of litter size specific interactions when litter size was added to
the model as an interactive term (data not included).
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Discussion

The pleiotropy, genetic heterogeneity, variable expressivity and incomplete
penetrance of congenital heart disease have been described exhaustively in the
literature as major hurdles in the characterization of risk 1,3,17. Individual risk is
difficult to assess even in the presence of a known mutation segregating in a family or
a knockout in an inbred animal strain due to yet undefined risk factors. While Nkx2-5
undoubtedly plays a major role in heart development 18-20, haploinsufficiency of the
gene is not sufficient to cause disease. In the Nkx2-5 knockout inbred mouse model,
it has been shown that the disease phenotype is heavily influenced by genetic
background. Each of the three strains studied C57Bl/6, FVB/n and A/J carry
susceptibility alleles at different loci for ventricular septal defects demonstrating the
influence of alternative genomic variability 8. Additionally, non-heritable sources of
variation such as litter size and maternal age further modify risk but only in specific
genetic backgrounds. Understanding why individuals with known predisposing
factors do not manifest the disease may provide insight into therapeutics that can
circumvent risk pathways21.
Variability within the VSD Phenotype
Congenital heart disease is a heterogeneous group of malformations in which
clinical taxonomy is not necessarily based on developmental etiology 22.
Intellectually there is a disconnect between the fields of cardiac development and
congenital heart disease which contrasts with fields like cancer biology and oncology
or basic and clinical immunology where one can feasibly envision how a discovery in
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the lab could be practically relevant to their respective medical fields. In this study we
have presented evidence that muscular and membranous VSD subtypes have distinct
genetic etiologies in this risk model. VSDs are generally described based on
physiologic location in the heart and not developmental etiology. Membranous
defects are found at the point where the septum reaches just under the aorta and
pulmonary arteries. In cross section, the defect shows a septum that takes on a
characteristic clean and rounded shape where the hole forms. In contrast, muscular
VSDs also called trabecular VSDs occur anywhere within the muscular portion of the
ventricular septum and vary in appearance from smooth to jagged edged.
Additionally, muscular VSDs often occur multiple times within one heart. While the
etiologies of these two defects remain unclear, it has been hypothesized that muscular
defects may be the result of incomplete proliferation of cardiomyocytes or excessive
resorbtion of the muscular septal wall during ventricular remodeling 23,24. This
contrasts with membranous VSDs which are more likely the result of insufficient
growth of the ventricular septal wall as it invaginates towards the endocardial cushion
during development.
The results of the linkage scans give evidence to support separate
developmental pathways and thus distinct genetic etiologies of these two defects.
However, there is potentially a common risk factor on chromosome 6. Given that
Nkx2-5 increases risk for both types of phenotypes, it is not unexpected that another
gene may direct a heart towards risk for either or both subtypes of VSDs. Fine
mapping regions of interest in the muscular VSD scan may reveal genes involved in
programmed cell death and remodeling whereas, the membranous candidates may
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reveal growth factors and genes that regulate them. The noisier appearance and lack
of significance of loci in the muscular scan may be due to a more heterogeneous
genetic pathway which is consistent with the increased variability observed in the
cross sections. However dissimilar these VSD subtypes may be in their origin, both
are considerably more likely to occur in an Nkx2-5 haploinsufficient individual
indicating that there is some commonality in their disease pathways. The disruption
caused by the knockout mutation is adequate to unlock the importance of underlying
buffering genetic variation that directs towards a particular disease phenotype. In
families with a segregating mutation in a major cardiac gene, risk may be governed
by a number of common variants that offer alternative pathways around the initial
disruption.

Variability within Membranous VSD Risk
Genome wide linkage mapped three significant risk loci for the membranous
VSD phenotype in the presence of Nkx2-5 haploinsufficiency. The presence of
multiple main effect modifiers is consistent with the polygenic models that have been
predicted in our lab and others for congenital heart malformations. We have reported
evidence through segregation analysis for at least 2 FVB/n specific risk alleles and 2
C57Bl/6 risk alleles which is further corroborated by the linkage scan results 8. In an
inbred mouse model in which ~99% of the alleles are fixed, it is intriguing that
polymorphisms between strains that have only recently diverged and come from a
limited gene pool have a substantial effect on VSD risk. These strain specific
differences are evidence that a greater source of underlying genetic variation is
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present in natural populations that is only subject to selection in the presence of a
major failure in the developmental pathway such as a major gene knockout or drastic
environmental change. An old system such as the heart is ideal for this variation
structure as it has been subject to many generations of stabilizing selection 25.
The Effect of Non heritable risk Factors
The concept of context specific genetic risk factors that are only important
under certain genetic or environmental circumstances is consistent with the lack of
reproducibility in many large genome association studies 25. The effect of maternal
age in the FVB/n F2 intercross and A/J exemplifies that the normally robust cardiac
developmental pathway can become vulnerable to non-heritable factors in the
presence of a major haploinsufficiency and the right (or wrong) genetic background.
Evolutionary Benefits of Variability
The Nkx2-5 heterozygous knockout model serves as an example of how a
major perturbation to the normally robust cardiac development pathway can result
predominantly in a healthy phenotype. The mosaic backgrounds of the F2 intercross
mice are a closed pool of variation in which bottled up genetic potential serves as the
major governing force of risk. G. Gibson described this as the effect of cryptic genetic
variation which can be present in any well canalized system which is evolutionarily
old and has experienced many generations of stabilizing selection 5. We propose that
the complexity of congenital heart disease is the result of important underlying
variability that is selectively beneficial in populations. Alleles of modifier genes have
the potential to increase risk or protect against it as well as direct presentation. A
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system in which underlying variation that is potentially protective is better equipped
to maintain developmental homeostasis than a single-variant determined system 26.
The fitness of the species is enhanced by the range of options presented by underlying
variation in modifier genes that normally have little or no detectable phenotypic
effect. A major perturbation of the system however can reveal an entire distribution of
important risk modifying alleles. This utilitarian mechanism provides a robust
developmental system to the majority while predisposing a minority to unfortunate
susceptibilities. In this study we have identified multiple sources of variability in a
simple model that any one of which represents an interesting pathway for scientists to
study or for clinicians to target.
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Figures:
Figure 3.1. Genome wide linkage scan result to map VSD risk loci in FVB/n F2
intercross mice. A total of 306 mice with VSDs and 284 controls were included in
this scan.

Figure 3.2. Genome wide linkage scan result to map membranous VSD specific
risk loci in FVB/n F2 intercross mice. A total of 251 mice with membranous
VSDs and 284 controls were included in this scan.

Figure 3.3. Genome wide linkage scan result to map muscular VSD specific risk
loci in FVB/n F2 intercross mice. A total of 80 mice with muscular VSDs and 284
controls were included in this scan.

Figure 3.4. Effect plots for significant loci mapped in the FVB/n F2 intercross
membranous VSD linkage scan. C/C = homozygous for C57Bl/6 alleles, C/F =
heterozygous for C57Bl6 and FVB/n alleles and F/F = homozygous for FVB/n
alleles. The y-axis represents that incidence of mice with membranous VSDs that
have the respective genotype indicated on the x-axis. Error bars are derived from
the imputed genotypes in interval mapping analysis.

Figure 3.5. Genome wide linkage scan result to map VSD risk loci in A/J F2
intercross mice. A total of 87 mice with membranous VSDs and 116 controls
were included in this scan.
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Figure 3.6. Effect plots for significant loci mapped in the A/J F2 intercross
membranous VSD linkage scan. C/C = homozygous for C57Bl/6 alleles, C/A =
heterozygous for C57Bl6 and A/J alleles and A/A = homozygous for A/J alleles.
The y-axis represents that incidence of mice with membranous VSDs that have
the respective genotype indicated on the x-axis. Error bars are derived from the
imputed genotypes in interval mapping analysis.

Figure 3.7. Incidence of VSD is plotted against maternal age (days) and litter
size.

Figure 3.8. Two-way scan for genetic interactions that correlate with
membranous VSD risk. The x-axis includes every marker location tested and the
resulting full model LOD scores color coded according the right hand key. The yaxis includes every marker location tested and the resulting epistatic LOD scores
color coded according to the left hand side of the key.
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Table 3.1. Incidence of VSDs in inbred mouse crosses

Cross
C57 Parent
F1 FVB Hybrid
F1 AJ Hybrid
F2 FVB Intercross
F2 AJ Intercross

VSD Incidence
Membranous
Muscular
7.5%
27.1%
1.3%
0.0%
0.0%
0.0%
9.7%
3.2%
8.2%
3.4%
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Figure 3.1
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Figure 3.2
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Figure 3.3

Figure 3.4
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Figure 3.5
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Figure 3.6

Table 3.2. Regression of Non-heritable predictors and VSD phenotypes
F2 Intercross
FVB/n

A/J

Mother
Father
Litter
Mother
Father
Litter

Membranous VSD
P-value
0.006
0.097
0.002
0.021
0.131
0.636

OR
4.07
0.45
0.92
3.96
2.23
0.98

95% CI
1.52-11.42
0.17-1.12
0.86-0.96
1.26-13.18
0.79-6.44
0.89-1.07

* P-value adjusted for correlation with other significant predictors
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Muscular VSD
P-value
OR
2.99
0.030
0.642
1.24
0.890
1.01
0.383
0.53
0.240
0.45
1.14
0.022

95% CI
1.12-8.18
0.50-3.03
0.93-1.07
0.13-2.27
0.11-1.74
1.07-1.28

Figure 3.7
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Figure 3.8

Table 3.3. Two-way scan candidate regions that exceeded threshold
conditions.

Condition 1
Epistatic Model
Locus 1 (cM)
Chr8@37.4
Chr6@52.3
Chr6@52.3

Locus 2 (cM)
Chr10@4.5
Chr10@4.5
Chr8@32.4

Full
13.901
13.509
12.926

Fv1
7.324
7.513
6.35

Int
2.378
1.689
0.254

Condition 2
Additive Model
Locus 1 (cM)
Chr6@52.3
Chr8@32.4
Chr6@52.3

Locus 2 (cM)
Chr8@32.4
Chr10@4.5
Chr10@4.5
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Add
12.672
11.875
11.821

Av1
6.095
5.299
5.824

Chapter 4: Conclusion and Future Directions

Genomic Mapping of Genetic Modifiers
In this study, an Nkx2-5 haploinsufficient mouse has served as a risk model for
the phenotypic variability of congenital heart disease risk that is commonly observed in
human studies. Through the examination of the incidences of congenital heart defects in
C57Bl/6 heterozygous knockout mice outcrossed to FVB/n and A/J as described in
Chapter 1, it has been determined that while Nkx2-5 mutation is a major risk factor for
heart defects, genetic background is crucial for directing penetrance and presentation of
those defects. Segregation analysis has implicated three or more modifier loci and at
least one epistatic interaction that influence susceptibility to muscular VSD and ASD in

Nkx2-5+/- animals. At least two loci influence membranous VSD susceptibility (Chapter
2).
Genomic mapping using F2 intercross strains has proven to be an effective
method for detecting and mapping candidate risk loci and interactions1. Significant
regions were mapped for membranous VSD risk on chromosomes 6, 8 and 10.
Additionally, the genome scan for muscular VSD risk loci revealed a potentially common
risk factor on chromosome 6 as well as a number of completely different suggestive
candidate regions elsewhere in the genome. Unfortunately, a caveat of using F2
generation outcrosses for gene mapping is that the candidate intervals are rather large
(20-40Mb) because there are only two generations of recombination. Lists of genes
located in these regions can be narrowed based on gene functionality and expression data.
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However, there is a risk that using filters based on known information will rule out small
effect genes that have novel roles in heart development. Given that only one of the
significant regions (chromosome 8) yielded genes that have been previously implicated in
heart development, this seems like a valid concern.
Also noted is the potential for multiple QTLs on a single chromosome. The
multiple peaks on chromosome 10 likely represent two and possibly three separate
candidate regions. It is possible that the middle peak in the 30cM region may simply be
an artifact of the two surrounding peaks being in linkage disequilibrium, however finer
resolution would be preferred over speculation.
Fine Mapping Strategy
An important future direction for this research project should include
implementing a strategy to narrow QTL intervals and resolve multiple peaks in order to
facilitate the identification of risk affecting loci. Fine-mapping with advanced intercross
lines (AIL) has been shown to be an effective method to accomplish this goal 2-4. AILs
are designed to increase the number of informative meioses in the mapping population by
continued intercrossing of a population to reduce linkage disequilibrium and cause the
proportion of recombinants between linked loci to asymptotically approach 0.5 5,6.
Animals from the F2 generation are continually intercrossed through successive
generations. The breeding is controlled so that siblings and first cousins are not mated to
avoid excessive inbreeding. Below is a schematic describing a semi-circular breeding
scheme based on the circular AIL screen described by Kimura and Crow7:
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Figure 4.1

Figure created by C. Schulkey

Animals from the F10 generation will be phenotyped and affected animals will be
genotyped for SNPs spaced 1-2 Mb across the genome to get high resolution mapping
information8. Linkage analysis on this new population will likely reveal considerably
greater resolution around candidate regions as up to a 5 fold reduction in confidence
interval compared to the F2 map has been reported using this method9. It is expected that
fine mapping with AILs will take 2-3 years for the crosses to be complete and the
adequate number of mice to be collected and diagnosed. At that point candidate regions
will be narrowed enough to allow for the search for functional variants. As of January of
2010, A/J has been sequenced with 23x coverage by the Mouse Genome Sequencing
Consortium at the Sanger Institute. While the FVB/n strain is not listed as a priority for
this consortium, hopefully it will be the next in line of mouse genomes to be sequenced
and therefore complete when the AIL analysis is. Clearly, direct alignment within
candidate regions would be an excellent source of information especially in non-coding
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regions. Other new avenues to explore include the potential for microRNAs being a
source of functional variance. The miRBase is continually being populated with more
information which will be particularly relevant when the candidate gene regions are more
finely mapped.

Further examination of Maternal Age Effect
The collection and diagnosis of 2,400 FVB/n and 1,370 A/J intercross mice at
high risk for congenital heart defects allowed for the unique opportunity to conduct an
epidemiological experiment in which a number of environmental factors could be
controlled for. For example, mice were kept in the same physical environment with the
same chow diet their whole lives. On the other hand, some non-heritable variables were
not controlled for such as maternal and paternal age and litter size. These variables were
recorded and later tested in a regression model as predictors of VSD risk. A significant
effect on membranous VSD risk was detected for maternal age and litter size in both
crosses.
Evidence for a maternal age affect in this congenital heart disease risk model is an
exciting find as it mimics findings in epidemiologic studies on human populations. It is
well documented that with advanced maternal age comes the increased risk for
chromosomal abnormalities in the offspring 10. Most notably, these copy number variants
(CNVs) are responsible for an increased risk of Down’s syndrome which is strongly
associated with congenital heart defects11. Therefore, one important way that the maternal
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age effect should be explored further is to check the F2 mice for increased CNVs in pups
with older mothers.
However, numerous studies have also been published reporting that incidence of
heart defects increase with advanced maternal age (35 yrs+) even when controlling for
chromosomal abnormalities such as Down’s syndrome12-14. Given that increased risk with
advanced maternal are may not be due to CNVs alone, the question arises as to whether
increased risk is the result of a change in older oocytes or with the physiologic
differences in the uterine environment that come with age. For example, it is clear that
fecundity decreases with advanced age which in mice is reportedly due to increased
resorption rates, morphological abnormalities of the embryos and delayed development
and not because of reduced ovulation or implantation rates15.
Potential changes in uterine environment include the effects of obesity and
diabetes. C57Bl/6 x FVB/n mice experience clear weight gain as they age which can lead
to changes in hormonal levels. Type II diabetes in these mothers could further affect
uterine environment as it does in humans which show increased risk for birth defects16. It
has been reported that C57Bl/6 mice are at risk for obesity and diabetes, however, A/J
mice are only at risk for obesity and do not show significant insulin resistance17. The
strain specific susceptibility to heart defects observed in this study would follow that
pattern since C57Bl/6 x A/J F2 mice did not show a significant maternal age effect on
incidence. Two potential experiments to address these hypotheses are 1) glucose
tolerance testing and 2) high fat diet for young mothers. The first experiments would
simply determine whether insulin insensitivity is increasing with age in our mice. Ideally,
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this study could be done prospectively throughout the life of a group of female F1 hybrid
mice, starting from weaning and ending with menopause. The second experiment would
address the obesity factor by attempting to accelerate the age/ risk correlation. Are the
younger, fatter mice having more pups with heart defects? Are they having pups with
comparable incidences to their older counterparts when they weigh the same?
Studies on human fertility report the existence of an opposing effect where oocytes
donated by young women to older women result in restored embryo implantation and pregnancy
rates indicating the problem lies with the aged oocytes and not the uterine environment18.

Therefore it seems important to evaluate pre-implantation and post-implantation changes
as risk modifying factors. Experiments which separate the oocyte from its environment
could potentially distinguish which factors are causing heart defects, the mother or the
egg. Oocytes from young donor mothers would be transferred by in vitro fertilization
procedures into older recipients (and young for control). Another experiment would
involve actually transferring ovaries from old mice (and young for control) into young
recipients. These experiments would be conducted in the Nkx2-5 heterozygous knockout
background. F2 pups produced in this manner would be collected and diagnosed using
standard procedures to determine the incidence of defects. Even if maternal age is
secondary to the real effect underlying the increase in congenital heart defects, these
experiments could potentially rule out a number of physiologic causes of risk to further
understand the basis of variance in congenital heart disease.
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